PrimeRFP SCOUT · Federal Contract Profile

Diasorin Molecular (KFFNMC55GHS5)Federal contracts · 3 recompetes

Diasorin Molecular holds $16.5M in federal volume across 436 award actions. SCOUT tracks 3 incumbent recompetes — an estimated $842K returning to market over the next 24 months (Moderate exposure). Primary work: In-Vitro Diagnostic Substance; Analytical Laboratory (100% prime). Obligations are down 114% year over year.

$16.5M

Federal Volume

Recompetes (24mo)

—

Top Agency

436

Award Actions

Choose one — this changes what we ask next

Score my firm against Diasorin Molecular

Email me when a Diasorin Molecular recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Work mix: 100% prime · 0% sub · primary NAICS 325413 / PSC 6630 CHEMICAL ANALYSIS INSTRUMENTS

Where they win

Sole agency

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$249K · 100% of firm total

Recompete exposure: Moderate · 3 in 24mo

Diasorin Molecular has an estimated $842K in contracts returning to market over the next 24 months.

Part of the DIASORIN MOLECULAR LLC corporate family · 5 entities

Metrics basis: local_db_api_validated

Who buys from them

Agency buyer map

1 buyers

Department of Defense (DOD)26 awards · repeat buyer · $249K

Recompete exposure & trajectory

Recompete exposure

Moderate

Diasorin Molecular has an estimated $842K in contracts returning to market over the next 24 months. 1 within 6 months ($552K).

SIMPLEXA COVID-19 TESTING SUPPLIES →

PIID: 36C25022P0732 · Expires 2026-10-31

$552K

HERPES VIROLOGY AND HISTOLOGY TESTING REAGENTS AND SUPPLIES →

PIID: 36C24126N0536 · Expires 2027-04-30

$150K

PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-22-P-0269 WITH DIASORIN MOLECUL →

PIID: W81K0022P0269 · Expires 2027-09-30

$140K

Trajectory

▼ Consolidating-114% YoYFY2025 vs FY2024

'23

'24

'25

“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”

— Gwyne Taylor, Tailored Global

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Diasorin Molecular hold?

Diasorin Molecular (UEI KFFNMC55GHS5) shows $16.5M across 436 award actions in SCOUT’s public USASpending-backed profile. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Diasorin Molecular have?

Diasorin Molecular shows $16.5M across 436 award actions. SCOUT tracks 3 incumbent recompetes ($842K) returning to market in the next 24 months.

Which agencies does Diasorin Molecular work with?

Diasorin Molecular’s firm-wide obligated mix is led by Department of Defense (DOD) (2%).

What is the UEI for Diasorin Molecular?

The Unique Entity ID (UEI) for Diasorin Molecular is KFFNMC55GHS5.

Does Diasorin Molecular have contracts coming up for recompete?

Yes — SCOUT tracks 3 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.